{"id":539322,"date":"2021-04-19T18:46:01","date_gmt":"2021-04-19T18:46:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=539322"},"modified":"2021-04-19T18:46:01","modified_gmt":"2021-04-19T18:46:01","slug":"market-competitive-opportunity-solution-help-a-medical-device-company-assess-the-landscape-of-cell-imaging-technology-domain-identify-top-competitors-through-competitive-intelligence-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/market-competitive-opportunity-solution-help-a-medical-device-company-assess-the-landscape-of-cell-imaging-technology-domain-identify-top-competitors-through-competitive-intelligence-delveinsight_539322.html","title":{"rendered":"Market & Competitive Opportunity Solution help a Medical Device Company Assess the Landscape of Cell Imaging Technology domain | Identify Top Competitors through Competitive Intelligence |DelveInsight"},"content":{"rendered":"
\"Market<\/a><\/p>\n
\n
Market & Competitive Opportunity<\/div>\n<\/div>\n<\/div>\n

(Albany, US) Traditional method of toxicity and drug safety studies is expensive, has a low success rate, and is resource- and time-consuming. To overcome these challenges, pharmaceutical companies are increasingly adopting high-content screening (HCS) cell-based assays for identifying the effects of toxicity in drug development studies (cell-based imaging enables the monitoring of drug toxicity mechanisms, such as oxidative stress, micronuclei, mitochondrial dysfunction, steatosis, and apoptosis).<\/p>\n

DelveInsight is the world’s leading independent provider of strategic market intelligence solutions. Our market intelligence services are designed to connect your organization’s goals with global opportunities.<\/p>\n

RFP to know more about DelveInsight’s competitive intelligence for pharma companies<\/a>.<\/strong><\/p>\n

 <\/p>\n

Business Problem:<\/strong><\/p>\n

A large Asian conglomerate was working to develop their asset portfolio in Cell Imaging and Analysis, and was interested to assess the market scenario of software based devices in the Cell Analysis and Cell Observation segment, such as HCS, Cell Analyzers, Flow Cytometers etc., to understand the past and forecasted market, to assess decision of possible market entry and potential future commercial success. The client requested evidence-based market estimation, segmented by type, end users, and application in US, EU, and some select APAC nations.<\/p>\n

 <\/p>\n

Download Case Study: https:\/\/www.delveinsight.com\/case-study\/market-&-competitive-assessment<\/a><\/strong><\/p>\n

 <\/p>\n

\"\"<\/em><\/strong><\/p>\n

Want comprehensive insights into the market drivers, challenges, key industry players, and more in the pharma <\/em>neonatal MSCs Opportunity Assessment? Request a free proposal<\/a><\/em><\/strong><\/p>\n

 <\/p>\n

Our Approach<\/strong><\/p>\n

Understanding Competition in the market, assess product portfolios and geographical reach to assess the landscape.<\/p>\n

Evaluating historical country- and company- based revenue and assessing relevant market segmentation.<\/p>\n

Deep-dive assessments into the device price and overall Market Size Assessment and Forecast and Outcome reporting.<\/p>\n

 <\/p>\n

DelveInsight is well versed in a multitude of qualitative and quantitative solutions to address your competitive intelligence needs. Learn more about our services portfolio for pharmaceutical companies. Request for more information<\/a>.<\/em><\/strong><\/p>\n

 <\/p>\n

Results:<\/strong><\/p>\n